PLXP
PLX PHARMA INC (PLXP)
$0.2799
Market is closedMarket is closed – opens on 8 PM, 09 Feb 2023
– opens on 8 PM, 09 Feb 2023
Performance
$0.275
Day's Range
$0.308
$0.13
52-Week Range
$6.66
| Returns % | |
| 1 month return | 39.53% |
| 3 month return | 52.56% |
| 1 year return | 95.52% |
| 5 year return | 95.5% |
Highlights
| Market Capitalization | 8.4M |
| Book Value | $0.35 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0% |
| Earnings Per Share (EPS) | -1.8 |
| PEG Ratio | -0.11 |
| Wall Street Target Price | 11.0 |
Company Financials
Peers
Analyst Recommendation
based on 6 analysts ratings
Sell
0%
Buy
50%
Hold
50%
Sell
Based on 6 Wall street analysts offering stock ratings for PLX PHARMA INC(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 3829.97%Current
$0.28
Target
$11.0
Recommendation Trend
Based on 6 analyst
| Current | 1M Ago | 3M Ago | |
| Buy | 0 | 4 | 0 |
| Hold | 3 | 0 | 4 |
| Sell | 3 | 0 | 3 |
| Consensus | SELL | BUY | HOLD |
Valuation
| Trailing PE | 0.0 |
| Forward PE | 0.0 |
| Price/Book (mrq) | 0.58 |
| Enterprise Value | 5.5M |
| Enterprise Value/Revenue | 1.21 |
| Enterprise Value/Ebitda | -0.09 |
Technicals
| Beta | 3.84 |
| 50 Day MA | 0.24 |
| 200 Day MA | 1.27 |
Institutional Holdings
Park West Asset Management LLC
5.06%
MSD Partners, L.P.
4.47%
Vanguard Group Inc
3.83%
BlackRock Inc
1.42%
Geode Capital Management, LLC
0.86%
Morgan Stanley - Brokerage Accounts
0.8%
Company Information
PLx Pharma Inc. is a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the gastrointestinal (GI) tract. PLx believes this has the potential to improve the absorption of many drugs currently on the market or in development, and to reduce the risk of stomach erosions and ulcers associated with aspirin and ibuprofen, and potentially other drugs.
| Organization | PLX PHARMA INC |
| Employees | 16 |
| CEO | Mr. Michael J. Valentino |
| Industry | Health Technology |
Discover more
Frequently Asked Questions
What is PLX PHARMA INC share price today?
Can Indians buy PLX PHARMA INC shares?
How can I buy PLX PHARMA INC shares from India?
Can Fractional shares of PLX PHARMA INC be purchased?
What are the documents required to start investing in PLX PHARMA INC stocks?
What are today’s High and Low prices of PLX PHARMA INC?
What are today’s traded volumes of PLX PHARMA INC?
What is today’s market capitalisation of PLX PHARMA INC?
What is the 52 Week High and Low Range of PLX PHARMA INC?
How much percentage PLX PHARMA INC is down from its 52 Week High?
How much percentage PLX PHARMA INC is up from its 52 Week low?
What are the historical returns of PLX PHARMA INC?
Who is the Chief Executive Officer (CEO) of PLX PHARMA INC?
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*